Mr. Friel currently serves as the Chairman and Chief Executive Officer of PerkinElmer. Mr. Friel served as our Chairman, Chief Executive Officer and President from February of 2008 through December of 2018. Prior to being appointed President and Chief Executive Officer in February 2008 and Chairman in April 2009, he had served as President and Chief Operating Officer since August 2007, and as Vice Chairman and President of our Life and Analytical Sciences unit since January 2006.
Mr. Friel was our Executive Vice President and Chief Financial Officer, with responsibility for business development and information technology in addition to his oversight of our finance functions, from October 2004 until January 2006. Mr. Friel joined PerkinElmer in February 1999 as our Senior Vice President and Chief Financial Officer. Prior to joining PerkinElmer, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. Mr. Friel received a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University. Mr. Friel currently serves on the board of directors of NuVasive, Inc. and Xylem Inc. He also previously served on the national board of trustees for the March of Dimes Foundation.
Mr. Friel has been one of the primary architects of PerkinElmer’s transformation into a global technology leader focused on innovating for a healthier world. Mr. Friel’s twenty years of executive experience with PerkinElmer has allowed him to develop a broad knowledge of our operations and activities, and that operational and leadership experience has been essential in formulating appropriate business strategies. His current and past service on the boards of other public companies has provided him with additional insights about service as the Chairman of our board.